Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...

Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...

The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)—which typically ...

The shift to a clear recommendation for vaccination goes beyond the prior guidance "just to encourage adults to talk to their ...

Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.

And now she knows she did everything she could to give Harper a healthy start. There was concern during a clinical trial with another RSV vaccine that it may cause preterm births, but the vaccine that ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...